Uttama Rath, PhD, MS

Oncolytic Biosimilars: An Opportunity to Reduce Oncology Treatment Costs

Clinical Pathways GPS

04/21/2020

Matthew Pakizegee, PharmD, MS

Richard Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor

Craig Ornstein, PhD, MA

Uttama Rath, PhD, MS

Jamey Hardesty, MPH

Inclusion of oncology biosimilars in clinical pathways is one approach to reducing costs in this therapeutic area without compromising outcomes for cancer patients. There are currently eight Food and Drug...

...

04/21/2020

Journal of Clinical Pathways

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

September 18 ⁠–⁠ September 20

September 20 ⁠–⁠ September 22

September 21 ⁠–⁠ September 22

September 30 ⁠–⁠ October 2

October 1 ⁠–⁠ October 2

October 2 ⁠–⁠ October 5

October 5 ⁠–⁠ October 6

October 14 ⁠–⁠ October 16

October 16 ⁠–⁠ October 19

October 19 ⁠–⁠ October 20

See Full Calendar

Uttama Rath, PhD, MS

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products